Kintara Therapeutics Investor Presentation — May 2021

Document content

Developing Advanced Oncology Therapies for Rare Unmet Medical Needs

Copyright © 2021 Kintara Therapeutics, Inc. CONFIDENTIAL

Corporate Presentation

May 2021Forward Looking Statements

This presentation contains forward -looking statements based upon Kintara’s current expectations. This communication contains “fo rward -looking

statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward -looking statements are identified by terminology such

as “may,” “should,” “expects,” “plans,” “anticipates,” “could,” “intends,” “target,” “projects,” “contemplates,” “believes,” “es timates,” “predicts,”

“potential” or “continue” or the negative of these terms or other similar words. These statements are only predictions. Kintara has based these

forward -looking statements largely on its then -current expectations and projections about future events, as well as the beliefs and assumptions of

management. Forward -looking statements are subject to a number of risks and uncertainties, many of which involve factors or circ umstances that are

beyond Kintara’s control, and actual results could differ materially from those stated or implied in forward -looking statements due to a number of

factors, including but not limited to: (i) risks associated with the impact of the COVID -19 pandemic; (ii) risks and uncertainties relating to Kintara’s

ability to develop, market and sell products based on its technology; the expected benefits and efficacy of Kintara’s product s and technology; the

availability of substantial additional funding for Kintara to continue its operations and to conduct research and development , clinical studies and

future product commercialization; and, Kintara’s business, research, product development, regulatory approval, marketing and dis tribution plans and

strategies (ii) whether the recently closed merger with Adgero Biopharmaceuticals will be successful, and (iii) those risks d etailed in Kintara’s most

recent Annual Report on Form 10- K and subsequent reports filed with the SEC, as well as other documents that may be filed by Kin tara from time to

time with the SEC. Accordingly, you should not rely upon forward -looking statements as predictions of future events. Kintara can not assure you that

the events and circumstances reflected in the forward -looking statements will be achieved or occur, and actual results could dif fer materially from

those projected in the forward -looking statements. The forward -looking statements made in this communication relate only to even ts as of the date

on which the statements are made. Except as required by applicable law or regulation, Kintara undertakes no obligation to upd ateany forward-looking